Iranian Journal of Microbiology · 2023 · 16 citations · 16 references
MedicineOncologyPharmacologyCancer PharmacologyDrug DeliveryNanoparticle Drug DeliveryAntibacterial AgentsBioactive Natural ProductsCancer NanomedicineMedicinal PlantsNanomedicineAnticancer ActivityAnticancer Natural ProductsChemical PropertiesDroplet Size DistributionDroplet Size MeasurementEssential Oil AnalysisNanoemulsionsZeta Potential Measurement
Background and Objectives: This study aimed to develop a natural nanoemulsion with antibacterial and anticancer prop- erties. Materials and Methods: The chemical composition of the Origanum majorana essential oil was investigated using GC–MS analysis. Besides, the successful loading of the essential oil in the nanoemulsion was confirmed using ATR-FTIR analysis. Moreover, nanoemulsion’s anticancer, antioxidant, and antibacterial activities were investigated. Results: Terpinen-4-o1 (46.90%) was identified as the major compound in the essential oil. The nanoemulsion with a 149 ± 5 nm droplet size and zeta potential of -11 ± 1 mV was prepared. The cytotoxic effect of the nanoemulsion against A-375 human melanoma cells (IC = 139 µg/mL) showed significantly more potency than A-549 human lung cancer cells (IC = 318 µg/mL). Interestingly, growth of Staphylococcus aureus (Gram-positive) and E. coli (Gram-negative) bacteria after treatment with 4800 µg/mL of nanoemulsion were obtained at 12 ± 2 and 6 ± 1%, respectively. However, the IC of nanoemulsion against E. coli (580 µg/mL) was not significantly different (P > 0.05) from S. aureus (611 µg/mL). Conclusion: A straightforward preparation method, high stability, and multi-biological effects are the main advantages of the prepared nanoemulsion. Therefore it could be considered for further investigation in vivo studies or complementary medicine.
16
Free Radicals and Extrinsic Skin Aging
Borut Poljšak, Raja Dahmane · Dermatology Research and Practice · 2012 · 310 citations · Full text
Life Sciences, Dermatology, Aging +15
Terpinen-4-ol: A Novel and Promising Therapeutic Agent for Human Gastrointestinal Cancers
Shiran Shapira, Shlomo Pleban, Diana Kazanov et al. · PLoS ONE · 2016 · 98 citations · Full text
Medicine, Oncology, Pharmacology +13